Financhill
Back

Sage Therapeutics Stock Predictions

Sage Therapeutics Stock Forecast

  • Over the next 52 weeks, Sage Therapeutics has on average historically risen by 16.2% based on the past 10 years of stock performance.
  • Sage Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Sage Therapeutics Stock Undervalued?
    The current Sage Therapeutics [SAGE] share price is $7.95. The Score for SAGE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sage Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sage Therapeutics has on average historically risen by 16.2% based on the past 10 years of stock performance.

Sage Therapeutics Stock Rating

Sell
36
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics overpriced?

  • Sage Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Sage Therapeutics Stock Price History

Is SAGE stock going to rise?

  • The current trend is moderately bearish and SAGE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com

52-Week Data

52-Week High:
18.76
52-Week Low:
4.62

Prediction Charts

Market Cap:
488.8M
Price in USD:
7.95
Volume:
1.6M
Beta:
1.29

Technical Analysis

SMA50:
7.48
SMA100:
6.58
SMA200:
7.80
52-Wk Change:
-57.58%

Stock Predictions

  • Is Sage Therapeutics stock public?
    Yes, Sage Therapeutics is a publicly traded company.
  • What is the Sage Therapeutics stock quote today?
    The Sage Therapeutics stock price is 7.95 USD today.
  • How to buy Sage Therapeutics stock online?
    You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-12 7.46 7.69 7.80 7.37
Mar-13 7.64 7.85 7.92 7.62
Mar-14 7.88 7.72 8.00 7.66
Mar-17 7.72 8.02 8.22 7.70
Mar-18 7.96 7.86 8.01 7.81
Mar-19 7.86 8.06 8.11 7.84
Mar-20 8.04 8.01 8.11 7.94
Mar-21 7.94 8.10 8.24 7.94
Mar-24 8.15 8.21 8.26 8.09
Mar-25 8.05 8.53 8.56 7.99
Mar-26 8.57 8.60 8.68 8.40
Mar-27 8.57 8.66 8.71 8.53
Mar-28 8.69 8.28 8.81 8.24
Mar-31 8.11 7.95 8.11 7.89

Sage Therapeutics Earnings

Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sage Therapeutics Forecast Revenue Growth

Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.42 per share, an increase this year of $2.66 per share, and an increase next year of $1.19 per share.

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.